Safety and efficacy of nintedanib (BIBF 1120) plus pemetrexed in Japanese patients with advanced or recurrent non-small cell lung cancer (NSCLC): A phase I study

被引：0
|
作者：
Daga, Haruko
Takeda, Koji
Okada, Hideaki
Miyazaki, Masaki
Ueda, Shinya
Kaneda, Hiroyasu
Okamoto, Isamu
Yoh, Kiyotaka
Goto, Koichi
Konishi, Koichi
Sarashina, Akiko
Yagi, Nobutaka
Mera, Kiyomi
Kaiser, Rolf
Nakagawa, Kazuhiko
机构：
[1] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan
[2] Kinki Univ, Dept Med Oncol, Osaka, Japan
[3] Kinki Univ, Osakasayama, Japan
[4] Natl Canc Ctr Hosp East, Div Thorac Oncol, Chiba, Japan
[5] Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan
[6] Nippon Boehringer Ingelheim Co Ltd, Med Dev Div, Tokyo, Japan
[7] Nippon Boehringer Ingelheim Co Ltd, Med Dev Div, Kobe, Hyogo, Japan
[8] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany
[9] Kinki Univ, Fac Med, Higashiosaka, Osaka 577, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8056
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer
    Clarke, SJ
    Boyer, MJ
    Millward, M
    Underhill, C
    Moylan, E
    Yip, D
    White, S
    Childs, A
    Beale, P
    Latz, J
    Suri, A
    Iglesias, JL
    LUNG CANCER, 2005, 49 (03) : 401 - 412
  • [42] Effect of race on the safety and efficacy of pemetrexed (P) therapy in locally advanced and metastatic non-small cell lung cancer (NSCLC)
    Tai, D. F.
    Kulkarni, P.
    Wang, Y.
    Gill, J.
    Obasaju, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Phase I Study of Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients with Locally Advanced Non-small Cell Lung Cancer
    Li, B.
    Yi, Y.
    Wang, Z.
    Sun, H.
    Gong, H.
    Zhang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S464 - S465
  • [44] Phase I Study of Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer
    Li, Bao-Sheng
    Gong, He-Yi
    Huang, Wei
    Yi, Yan
    Yu, Jin-Mimg
    Wang, Zhong-Tang
    Zhang, Zi-Cheng
    Sun, Hong-Fu
    Li, Hong-Sheng
    Wang, Li-Ying
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 115 - 119
  • [45] Updated efficacy and safety data from the phase I/II ARROW study of pralsetinib in patients (pts) with advanced RET fusion plus non-small cell lung cancer (NSCLC)
    Besse, B.
    Griesinger, F.
    Curigliano, G.
    Thomas, M.
    Subbiah, V.
    Baik, C. S.
    Tan, D. S. W.
    Lee, D. H.
    Garralda, E.
    Kim, D-W.
    Van Der Wekken, A. J.
    Gainor, J.
    Paz-Ares, L.
    Liu, S. V.
    Bowles, D. W.
    Zalutskaya, A.
    Ruf, T.
    Rahman, A.
    Chen, G.
    Mazieres, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1083 - S1084
  • [46] Phase (Ph) I study of the safety and efficacy of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced cMET plus non-small cell lung cancer (NSCLC).
    Schuler, Martin H.
    Berardi, Rossana
    Lim, Wan-Teck
    Van Geel, Robin
    De Jonge, Maja J.
    Bauer, Todd Michael
    Azaro, Analia
    Gottfried, Maya
    Han, Ji-Youn
    Lee, Dae Ho
    Wollner, Mira
    Hong, David S.
    Vogel, Arndt
    Delmonte, Angelo
    Krohn, Alexander
    Zhang, Yong
    Squires, Matthew
    Giovannini, Monica
    Akimov, Mikhail
    Bang, Yung-Jue
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [48] Multicenter phase II study of cisplatin, pemetrexed, plus bevacizumab followed by maintenance pemetrexed plus bevacizumab for patients with advanced or recurrent non-squamous non-small cell lung cancer: MAP study
    Tsutani, Y.
    Miyata, Y.
    Masuda, T.
    Fujitaka, K.
    Doi, M.
    Awaya, Y.
    Kuyama, S.
    Kitaguchi, S.
    Ueda, K.
    Okada, M.
    ANNALS OF ONCOLOGY, 2017, 28 : 137 - 137
  • [49] Efficacy and safety study of osimertinib in advanced non-small cell lung cancer (NSCLC) with EGFR mutation
    Garcia Samblas, Victoria
    Fernandez Madrigal, Laura
    Rodriguez Garces, Maria Yeray
    Inoriza, Angel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease
    Fujita, Tetsuo
    Kuroki, Tsuguko
    Hayama, Nami
    Shiraishi, Yuka
    Amano, Hiroyuki
    Nakamura, Makoto
    Hirano, Satoshi
    Tabeta, Hiroshi
    Nakamura, Sukeyuki
    IN VIVO, 2019, 33 (06): : 2059 - 2064
12345